nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—Dextrothyroxine—hypothyroidism	0.207	0.249	CbGbCtD
Gemfibrozil—SLCO1B1—Liothyronine—hypothyroidism	0.157	0.189	CbGbCtD
Gemfibrozil—SLCO1B1—Levothyroxine—hypothyroidism	0.157	0.189	CbGbCtD
Gemfibrozil—SLCO1B1—Liotrix—hypothyroidism	0.153	0.184	CbGbCtD
Gemfibrozil—CYP2C8—Levothyroxine—hypothyroidism	0.0665	0.0798	CbGbCtD
Gemfibrozil—CYP2C8—Liotrix—hypothyroidism	0.0649	0.0779	CbGbCtD
Gemfibrozil—CYP3A4—Levothyroxine—hypothyroidism	0.027	0.0324	CbGbCtD
Gemfibrozil—PPARA—brown adipose tissue—hypothyroidism	0.0175	0.275	CbGeAlD
Gemfibrozil—CYP2C19—urine—hypothyroidism	0.0046	0.0723	CbGeAlD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.00416	0.135	CbGpPWpGaD
Gemfibrozil—CYP1A2—urine—hypothyroidism	0.00375	0.059	CbGeAlD
Gemfibrozil—CYP2C9—urine—hypothyroidism	0.00356	0.056	CbGeAlD
Gemfibrozil—PPARA—Nuclear Receptors—THRA—hypothyroidism	0.00307	0.0999	CbGpPWpGaD
Gemfibrozil—PPARA—heart—hypothyroidism	0.00284	0.0446	CbGeAlD
Gemfibrozil—CYP3A4—urine—hypothyroidism	0.00272	0.0427	CbGeAlD
Gemfibrozil—PPARA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—NKX2-5—hypothyroidism	0.00272	0.0884	CbGpPWpGaD
Gemfibrozil—PPARA—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00268	0.0872	CbGpPWpGaD
Gemfibrozil—PPARA—cardiovascular system—hypothyroidism	0.00268	0.0421	CbGeAlD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00243	0.079	CbGpPWpGaD
Gemfibrozil—PPARA—adrenal gland—hypothyroidism	0.00212	0.0333	CbGeAlD
Gemfibrozil—PPARA—blood—hypothyroidism	0.00212	0.0333	CbGeAlD
Gemfibrozil—PPARA—thyroid gland—hypothyroidism	0.00204	0.0321	CbGeAlD
Gemfibrozil—PPARA—Nuclear Receptors—THRB—hypothyroidism	0.00198	0.0644	CbGpPWpGaD
Gemfibrozil—PPARA—female gonad—hypothyroidism	0.00197	0.031	CbGeAlD
Gemfibrozil—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00181	0.025	CcSEcCtD
Gemfibrozil—Muscular weakness—Levothyroxine—hypothyroidism	0.00181	0.025	CcSEcCtD
Gemfibrozil—PPARA—testis—hypothyroidism	0.00175	0.0275	CbGeAlD
Gemfibrozil—PPARA—liver—hypothyroidism	0.00165	0.026	CbGeAlD
Gemfibrozil—PPARA—cerebellum—hypothyroidism	0.00162	0.0254	CbGeAlD
Gemfibrozil—Weight decreased—Levothyroxine—hypothyroidism	0.0016	0.0221	CcSEcCtD
Gemfibrozil—Weight decreased—Dextrothyroxine—hypothyroidism	0.0016	0.0221	CcSEcCtD
Gemfibrozil—PPARA—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00156	0.0509	CbGpPWpGaD
Gemfibrozil—SLCO1B1—blood—hypothyroidism	0.00135	0.0212	CbGeAlD
Gemfibrozil—Muscular weakness—Liotrix—hypothyroidism	0.00133	0.0184	CcSEcCtD
Gemfibrozil—Alopecia—Levothyroxine—hypothyroidism	0.00125	0.0173	CcSEcCtD
Gemfibrozil—Alopecia—Dextrothyroxine—hypothyroidism	0.00125	0.0173	CcSEcCtD
Gemfibrozil—Tension—Dextrothyroxine—hypothyroidism	0.00121	0.0167	CcSEcCtD
Gemfibrozil—Tension—Levothyroxine—hypothyroidism	0.00121	0.0167	CcSEcCtD
Gemfibrozil—Nervousness—Dextrothyroxine—hypothyroidism	0.0012	0.0166	CcSEcCtD
Gemfibrozil—Nervousness—Levothyroxine—hypothyroidism	0.0012	0.0166	CcSEcCtD
Gemfibrozil—SLCO1B1—Transport of organic anions—AVP—hypothyroidism	0.0012	0.039	CbGpPWpGaD
Gemfibrozil—Weight decreased—Liotrix—hypothyroidism	0.00118	0.0163	CcSEcCtD
Gemfibrozil—Renal failure—Liotrix—hypothyroidism	0.00114	0.0158	CcSEcCtD
Gemfibrozil—Angioedema—Levothyroxine—hypothyroidism	0.00113	0.0156	CcSEcCtD
Gemfibrozil—Angioedema—Dextrothyroxine—hypothyroidism	0.00113	0.0156	CcSEcCtD
Gemfibrozil—Convulsion—Dextrothyroxine—hypothyroidism	0.00107	0.0148	CcSEcCtD
Gemfibrozil—Convulsion—Levothyroxine—hypothyroidism	0.00107	0.0148	CcSEcCtD
Gemfibrozil—SLCO1B1—liver—hypothyroidism	0.00106	0.0166	CbGeAlD
Gemfibrozil—Arthralgia—Dextrothyroxine—hypothyroidism	0.00105	0.0145	CcSEcCtD
Gemfibrozil—Arthralgia—Levothyroxine—hypothyroidism	0.00105	0.0145	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Liotrix—hypothyroidism	0.00104	0.0143	CcSEcCtD
Gemfibrozil—Confusional state—Dextrothyroxine—hypothyroidism	0.00102	0.014	CcSEcCtD
Gemfibrozil—Confusional state—Levothyroxine—hypothyroidism	0.00102	0.014	CcSEcCtD
Gemfibrozil—Shock—Levothyroxine—hypothyroidism	0.000991	0.0137	CcSEcCtD
Gemfibrozil—Shock—Dextrothyroxine—hypothyroidism	0.000991	0.0137	CcSEcCtD
Gemfibrozil—Alopecia—Liotrix—hypothyroidism	0.000922	0.0127	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000918	0.0127	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000918	0.0127	CcSEcCtD
Gemfibrozil—CYP2C9—heart—hypothyroidism	0.000913	0.0144	CbGeAlD
Gemfibrozil—Flatulence—Liotrix—hypothyroidism	0.000895	0.0124	CcSEcCtD
Gemfibrozil—Tension—Liotrix—hypothyroidism	0.000891	0.0123	CcSEcCtD
Gemfibrozil—Dysgeusia—Liotrix—hypothyroidism	0.000889	0.0123	CcSEcCtD
Gemfibrozil—Nervousness—Liotrix—hypothyroidism	0.000882	0.0122	CcSEcCtD
Gemfibrozil—CYP2C19—blood—hypothyroidism	0.000879	0.0138	CbGeAlD
Gemfibrozil—Fatigue—Levothyroxine—hypothyroidism	0.000869	0.012	CcSEcCtD
Gemfibrozil—Fatigue—Dextrothyroxine—hypothyroidism	0.000869	0.012	CcSEcCtD
Gemfibrozil—CYP2C9—cardiovascular system—hypothyroidism	0.000862	0.0135	CbGeAlD
Gemfibrozil—CYP2C8—pituitary gland—hypothyroidism	0.000859	0.0135	CbGeAlD
Gemfibrozil—Vision blurred—Liotrix—hypothyroidism	0.000856	0.0118	CcSEcCtD
Gemfibrozil—Feeling abnormal—Levothyroxine—hypothyroidism	0.00083	0.0115	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00083	0.0115	CcSEcCtD
Gemfibrozil—Angioedema—Liotrix—hypothyroidism	0.00083	0.0115	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000824	0.0114	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000824	0.0114	CcSEcCtD
Gemfibrozil—Syncope—Liotrix—hypothyroidism	0.000814	0.0112	CcSEcCtD
Gemfibrozil—PPARA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypothyroidism	0.000805	0.0262	CbGpPWpGaD
Gemfibrozil—Urticaria—Levothyroxine—hypothyroidism	0.000801	0.0111	CcSEcCtD
Gemfibrozil—Urticaria—Dextrothyroxine—hypothyroidism	0.000801	0.0111	CcSEcCtD
Gemfibrozil—Loss of consciousness—Liotrix—hypothyroidism	0.000798	0.011	CcSEcCtD
Gemfibrozil—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000797	0.011	CcSEcCtD
Gemfibrozil—Abdominal pain—Levothyroxine—hypothyroidism	0.000797	0.011	CcSEcCtD
Gemfibrozil—Convulsion—Liotrix—hypothyroidism	0.000787	0.0109	CcSEcCtD
Gemfibrozil—Arthralgia—Liotrix—hypothyroidism	0.000773	0.0107	CcSEcCtD
Gemfibrozil—Chest pain—Liotrix—hypothyroidism	0.000773	0.0107	CcSEcCtD
Gemfibrozil—CYP2C8—blood—hypothyroidism	0.000767	0.0121	CbGeAlD
Gemfibrozil—Confusional state—Liotrix—hypothyroidism	0.000747	0.0103	CcSEcCtD
Gemfibrozil—Oedema—Liotrix—hypothyroidism	0.000741	0.0102	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Liotrix—hypothyroidism	0.000741	0.0102	CcSEcCtD
Gemfibrozil—Shock—Liotrix—hypothyroidism	0.000729	0.0101	CcSEcCtD
Gemfibrozil—Asthenia—Levothyroxine—hypothyroidism	0.000723	0.00999	CcSEcCtD
Gemfibrozil—Asthenia—Dextrothyroxine—hypothyroidism	0.000723	0.00999	CcSEcCtD
Gemfibrozil—CYP1A2—blood—hypothyroidism	0.000718	0.0113	CbGeAlD
Gemfibrozil—Pruritus—Levothyroxine—hypothyroidism	0.000713	0.00985	CcSEcCtD
Gemfibrozil—Pruritus—Dextrothyroxine—hypothyroidism	0.000713	0.00985	CcSEcCtD
Gemfibrozil—CYP1A2—thyroid gland—hypothyroidism	0.000693	0.0109	CbGeAlD
Gemfibrozil—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000689	0.00952	CcSEcCtD
Gemfibrozil—Diarrhoea—Levothyroxine—hypothyroidism	0.000689	0.00952	CcSEcCtD
Gemfibrozil—CYP2C19—liver—hypothyroidism	0.000687	0.0108	CbGeAlD
Gemfibrozil—CYP2C9—blood—hypothyroidism	0.000681	0.0107	CbGeAlD
Gemfibrozil—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000675	0.00933	CcSEcCtD
Gemfibrozil—Paraesthesia—Liotrix—hypothyroidism	0.000666	0.00919	CcSEcCtD
Gemfibrozil—PPARA—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000651	0.0212	CbGpPWpGaD
Gemfibrozil—Vomiting—Levothyroxine—hypothyroidism	0.000641	0.00885	CcSEcCtD
Gemfibrozil—Vomiting—Dextrothyroxine—hypothyroidism	0.000641	0.00885	CcSEcCtD
Gemfibrozil—Fatigue—Liotrix—hypothyroidism	0.000639	0.00883	CcSEcCtD
Gemfibrozil—Rash—Levothyroxine—hypothyroidism	0.000635	0.00878	CcSEcCtD
Gemfibrozil—Rash—Dextrothyroxine—hypothyroidism	0.000635	0.00878	CcSEcCtD
Gemfibrozil—Dermatitis—Dextrothyroxine—hypothyroidism	0.000635	0.00877	CcSEcCtD
Gemfibrozil—Dermatitis—Levothyroxine—hypothyroidism	0.000635	0.00877	CcSEcCtD
Gemfibrozil—CYP2C8—testis—hypothyroidism	0.000635	0.00998	CbGeAlD
Gemfibrozil—Constipation—Liotrix—hypothyroidism	0.000634	0.00876	CcSEcCtD
Gemfibrozil—Headache—Dextrothyroxine—hypothyroidism	0.000631	0.00872	CcSEcCtD
Gemfibrozil—Headache—Levothyroxine—hypothyroidism	0.000631	0.00872	CcSEcCtD
Gemfibrozil—Feeling abnormal—Liotrix—hypothyroidism	0.000611	0.00844	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Liotrix—hypothyroidism	0.000606	0.00837	CcSEcCtD
Gemfibrozil—CYP2C8—liver—hypothyroidism	0.0006	0.00943	CbGeAlD
Gemfibrozil—Nausea—Dextrothyroxine—hypothyroidism	0.000599	0.00827	CcSEcCtD
Gemfibrozil—Nausea—Levothyroxine—hypothyroidism	0.000599	0.00827	CcSEcCtD
Gemfibrozil—Urticaria—Liotrix—hypothyroidism	0.000589	0.00813	CcSEcCtD
Gemfibrozil—PPARA—Circadian Clock—AVP—hypothyroidism	0.000586	0.0191	CbGpPWpGaD
Gemfibrozil—Abdominal pain—Liotrix—hypothyroidism	0.000586	0.00809	CcSEcCtD
Gemfibrozil—CYP1A2—liver—hypothyroidism	0.000561	0.00882	CbGeAlD
Gemfibrozil—PPARA—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000547	0.0178	CbGpPWpGaD
Gemfibrozil—CYP2C9—liver—hypothyroidism	0.000533	0.00838	CbGeAlD
Gemfibrozil—Asthenia—Liotrix—hypothyroidism	0.000532	0.00735	CcSEcCtD
Gemfibrozil—Pruritus—Liotrix—hypothyroidism	0.000524	0.00724	CcSEcCtD
Gemfibrozil—CYP3A4—blood—hypothyroidism	0.00052	0.00817	CbGeAlD
Gemfibrozil—Diarrhoea—Liotrix—hypothyroidism	0.000507	0.00701	CcSEcCtD
Gemfibrozil—Dizziness—Liotrix—hypothyroidism	0.00049	0.00677	CcSEcCtD
Gemfibrozil—Vomiting—Liotrix—hypothyroidism	0.000471	0.00651	CcSEcCtD
Gemfibrozil—Rash—Liotrix—hypothyroidism	0.000467	0.00646	CcSEcCtD
Gemfibrozil—Dermatitis—Liotrix—hypothyroidism	0.000467	0.00645	CcSEcCtD
Gemfibrozil—Headache—Liotrix—hypothyroidism	0.000464	0.00641	CcSEcCtD
Gemfibrozil—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000445	0.0145	CbGpPWpGaD
Gemfibrozil—Nausea—Liotrix—hypothyroidism	0.00044	0.00608	CcSEcCtD
Gemfibrozil—PPARA—Generic Transcription Pathway—THRA—hypothyroidism	0.000419	0.0136	CbGpPWpGaD
Gemfibrozil—CYP3A4—liver—hypothyroidism	0.000406	0.00639	CbGeAlD
Gemfibrozil—PPARA—Gene Expression—ZNF764—hypothyroidism	0.000313	0.0102	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000303	0.00987	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000299	0.00972	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000273	0.00889	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—THRB—hypothyroidism	0.00027	0.00879	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000251	0.00818	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000226	0.00736	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—CLTC—hypothyroidism	0.000223	0.00725	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—AVP—hypothyroidism	0.000208	0.00676	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—THRA—hypothyroidism	0.000202	0.00657	CbGpPWpGaD
Gemfibrozil—PPARA—Adipogenesis—IGF1—hypothyroidism	0.000188	0.00612	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—IYD—hypothyroidism	0.000185	0.006	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ATP5O—hypothyroidism	0.000157	0.00511	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000154	0.00501	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—TPO—hypothyroidism	0.000148	0.0048	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—NKX2-5—hypothyroidism	0.000144	0.00468	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000137	0.00445	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—THRB—hypothyroidism	0.00013	0.00423	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000128	0.00416	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000121	0.00394	CbGpPWpGaD
Gemfibrozil—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000118	0.00383	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000109	0.00355	CbGpPWpGaD
Gemfibrozil—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000105	0.00342	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—VAV3—hypothyroidism	0.000105	0.00342	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—IYD—hypothyroidism	0.000104	0.00339	CbGpPWpGaD
Gemfibrozil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	9.59e-05	0.00312	CbGpPWpGaD
Gemfibrozil—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	9.55e-05	0.00311	CbGpPWpGaD
Gemfibrozil—SLCO1B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	9.55e-05	0.00311	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ATP5O—hypothyroidism	8.86e-05	0.00288	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—AVP—hypothyroidism	8.6e-05	0.0028	CbGpPWpGaD
Gemfibrozil—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	8.52e-05	0.00277	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—TPO—hypothyroidism	8.33e-05	0.00271	CbGpPWpGaD
Gemfibrozil—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	8.19e-05	0.00267	CbGpPWpGaD
Gemfibrozil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.77e-05	0.00253	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.71e-05	0.00251	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—TSHB—hypothyroidism	6.83e-05	0.00222	CbGpPWpGaD
Gemfibrozil—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.64e-05	0.00216	CbGpPWpGaD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.32e-05	0.00206	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.16e-05	0.002	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3C2A—hypothyroidism	6.09e-05	0.00198	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	6.01e-05	0.00195	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—IYD—hypothyroidism	5.98e-05	0.00195	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—IYD—hypothyroidism	5.34e-05	0.00174	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.13e-05	0.00167	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—SLC5A5—hypothyroidism	5.11e-05	0.00166	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ATP5O—hypothyroidism	5.09e-05	0.00166	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—POMC—hypothyroidism	5.07e-05	0.00165	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—IYD—hypothyroidism	4.87e-05	0.00158	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.85e-05	0.00158	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TPO—hypothyroidism	4.78e-05	0.00156	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ATP5O—hypothyroidism	4.54e-05	0.00148	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—POMC—hypothyroidism	4.53e-05	0.00147	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.43e-05	0.00144	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TPO—hypothyroidism	4.27e-05	0.00139	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—IYD—hypothyroidism	4.16e-05	0.00135	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ATP5O—hypothyroidism	4.14e-05	0.00135	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—POMC—hypothyroidism	4.13e-05	0.00134	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.96e-05	0.00129	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TPO—hypothyroidism	3.89e-05	0.00127	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—TSHB—hypothyroidism	3.85e-05	0.00125	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.61e-05	0.00117	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ATP5O—hypothyroidism	3.54e-05	0.00115	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—POMC—hypothyroidism	3.53e-05	0.00115	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	3.44e-05	0.00112	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.39e-05	0.0011	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TPO—hypothyroidism	3.33e-05	0.00108	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—IYD—hypothyroidism	3.21e-05	0.00105	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.08e-05	0.001	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	2.89e-05	0.000939	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.73e-05	0.000889	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.72e-05	0.000886	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—POMC—hypothyroidism	2.68e-05	0.00087	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TPO—hypothyroidism	2.57e-05	0.000836	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TSHB—hypothyroidism	2.22e-05	0.000721	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TSHB—hypothyroidism	1.98e-05	0.000643	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	1.97e-05	0.000642	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.95e-05	0.000634	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TSHB—hypothyroidism	1.8e-05	0.000587	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	1.76e-05	0.000573	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.74e-05	0.000566	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC5A5—hypothyroidism	1.66e-05	0.000539	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	1.61e-05	0.000523	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.59e-05	0.000516	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TSHB—hypothyroidism	1.54e-05	0.000501	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—POMC—hypothyroidism	1.51e-05	0.000491	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC5A5—hypothyroidism	1.48e-05	0.000482	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	1.37e-05	0.000447	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.35e-05	0.000441	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC5A5—hypothyroidism	1.35e-05	0.000439	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TSHB—hypothyroidism	1.19e-05	0.000387	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC5A5—hypothyroidism	1.15e-05	0.000375	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.06e-05	0.000345	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC5A5—hypothyroidism	8.9e-06	0.00029	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—POMC—hypothyroidism	8.68e-06	0.000282	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—POMC—hypothyroidism	7.74e-06	0.000252	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—POMC—hypothyroidism	7.06e-06	0.00023	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—POMC—hypothyroidism	6.03e-06	0.000196	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—POMC—hypothyroidism	4.66e-06	0.000152	CbGpPWpGaD
